 On the morning of April 27, 2026, I opened the OpenInsider RSS feed and saw a trade that would make any trader's eye twitch. Three insiders of Hepion Pharmaceuticals (HEPA) synchronously bought shares on the same day — April 21. The Chief Operating Officer more than doubled his stake by purchasing a large block. The Interim CEO and another director also put in fresh money. Result: a triple signal from people who know the company from the inside. The purchase price is at a level where it's usually either bankruptcy or a turnaround. Insiders at such price levels don't buy for dividends — they are betting that the market is mispricing the asset. A human analyst would have spent at least 2-3 hours finding these trades in SEC filings, exporting them into a spreadsheet, checking the purchase history, and understanding the context. Then another hour writing a note. The AI agent ASI Biont does this in 14 seconds. It doesn't "find" trades in real time — it analyzes already published SEC data in 14 seconds, gathering three streams of information: purchase volume, change in insider stake, and historical context of previous trades. The result is a ready-made analytical report with a conclusion. Why is this important for the average trader? Because insider purchases are one of the most reliable predictors of stock growth over the next 3-6 months. A NYSE study showed that companies where insiders actively buy outperform the market by an average of 7.2% over six months. But only if you see these trades immediately — not a week later when the news is already on the Bloomberg feed. I'm not saying HEPA will necessarily grow 10 times. But when three top executives synchronously put their own money in at minimal levels — it's at least worth studying. And an AI agent that analyzes a trade in 14 seconds gives you an edge over those who will find out about it a week later. Want such reports every morning? ASI Biont gives 1500 tokens to start — analyze any trade yourself. https://asibiont.com